Free Daily Podcast Summary
The Space: Life Sciences Podcast: Daily Summaries Delivered
by Marc Iskowitz, Beghou
Marc Iskowitz, Beghou's editorial director, hosts behind-the-scenes conversations with biopharma executives. This series will feature leaders from across the biotech and pharma ecosystem, spanning commercial ops, field force, medical, marketing, analytics, market access, and beyond, sharing real-world lessons from the front lines of bringing therapies to patients.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- Today25 min
How pharma commercial teams can move past barriers to achieve meaningful AI adoption
Results of a recent Beghou study reveal a high level of AI experimentation among biopharma commercial execs but a lack of enterprise integration. What’s preventing a more sustained level of uptake? According to study co-leader Brett Ramos, Senior Director of Commercial Operations and Analytics at Neurelis, adoption has been a mixed bag. has been a mixed bag. That's not due merely to AI access. The study revealed a combination of high interest and low fear, suggesting the barrier is structural. Ramos and his study co-lead, Beghou Partner Nicole Ventrone, mapped AI usage, as well as the main barriers and drivers to sustained adoption. In many cases, they were surprised to see where AI was clustering and where it was not.They compiled those data into a behavioral segmentation framework categorizing individuals by their orientation toward the technology, as well as what each of eight different personas needs to use AI with confidence and in a practical, sustained way. In this podcast, Ramos not only demystifies common AI myths. He also points out prevalent stigmas, i.e., when colleagues are subtly shamed for using AI instead of rewarded. And he provides a segmentation framework that enables personalized approaches for rolling out the technology. Read the report brief for more on the Commercialization That Works: AI Enablement survey (April 2026) findings: [Turning individual AI experimentation into sustained adoption and value in life sciences]Also, read our article for more about the common assumptions surrounding AI adoption that were challenged by the survey findings: Biopharma’s own AI myth-busters separate tall tale from truism [https://beghou.com/blog/ai-adoption-personas-biopharma-commercial-teams]
- Sep 16, 202633 min
Oncology Confidential: Candid Perspectives From a 28-Year Oncology Sales Veteran
For years, biopharma companies competed in what one analyst called a "sales-force arms race," believing more reps meant better results. That era is long gone, but today's commercial challenge is arguably even more difficult. Physician access has become increasingly scarce, while commercial organizations have grown more specialized. Sales, medical, market access, and other functions each play a critical role, but how do you ensure physicians get everything they need to make informed treatment decisions during the few minutes they have with your team? In this episode, veteran oncology commercialization exec Perry Monaco shares his perspective on the future of customer engagement, explaining why success depends less on creating more interactions than on making every interaction more valuable through smarter orchestration, better use of data and AI, and a commercial model designed around the needs of physicians and patients. Perry also reflects on the formative experience that first drew him to oncology, and how it shaped him as both a commercial leader and a person.
- Jun 17, 202625 min
Why capital efficiency anchors biotech’s new commercial playbook
As biotech navigates a mixed funding and dealmaking environment in 2026, one principle continues to guide the commercial playbook: capital efficiency. So says Jacob Lai, Vice President and Head of Commercial at Star Therapeutics, who sat down with Marc Iskowitz in the latest episode of The Space Life Sciences Podcast to discuss how that environment is shaping go-to-market strategy. Jacob explains why biotech’s modest resurgence, with capital markets becoming more selective, highlights the continued importance of being capital-efficient and how commercial teams can make smarter investments in data and analytics infrastructure. Of course, the conversation also explores the growing impact of AI, and Jacob shares his vision for commercial ops as a driver of organizational change for some of these new modalities.
- May 21, 202628 min
Moving clinical minds: Why strong data don't always translate into clinical adoption
"If the evidence is compelling, why isn't practice evolving?" That was Audrey Carnevale's “welcome to pharma” moment — the realization that strong data doesn't automatically translate into changes in clinical adoption. Now Associate Director of Medical Communications at Averitas Pharma (and an MSL before that), Audrey joins Marc Iskowitz in the second episode of The Space podcast. She talks about how the medical function can move clinical minds by: - Sharpening focus so that the data shared are hyper-relevant for each audience (HCPs, payers, and patients) - Working as a strategic contributor (not just a reviewer) to shape disease understanding before the product enters the conversation - Layering data and evidence to help clinicians move from simple awareness to true clinical confidence Intro: Why Strong Data Don't Always Drive Clinical Change Audrey's Journey: From MSL to In-House Medical Communications The Role of Medical Communications at Averitas Pharma Aligning Medical & Commercial: A Recurring Industry Challenge Medical's Strategic Advantage Before Launch Mapping the HCP Journey & Plugging the Educational Gaps AI in Medical Affairs: Real Use Cases Misconceptions: What Medical Wants Commercial to Know
- Apr 27, 202618 min
Fixing pre-launch commercial ops mistakes
Operating model. Launch readiness. Data. Execution. Get these wrong, and even the most promising therapy can stall. Get them right, and you get product to patient — and that’s what drives Lori Nemyier every day. In this inaugural episode of the Space Life Sciences Podcast, Marc Iskowitz sits down with Lori to unpack a critical question for emerging biotechs: Why do so many companies struggle to execute at launch, and how can they get it right the first time? Drawing on more than two decades of experience across specialty pharma and startup environments, Lori shares what she’s learned from stepping into companies at pivotal inflection points — often tasked with building or rebuilding commercial operations from the ground up. Introduction What draws Lori to early-stage biotech startups Lori's "Welcome to Biopharma" moment Challenges of launching in cell and gene therapy Data acquisition strategy before a drug launch The #1 tip for winning at launch Real example: Getting tech and data to work in sync Where AI is effective in life sciences The biggest AI opportunities in biopharma Final advice for commercial leaders
Get The Space: Life Sciences Podcast summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
The BioHub - by Avetix
Conversations with leading biotech experts reveal the strategies and stories driving innovation in the biotechnology industry.
In the Interim...
Explores Bayesian statistics and adaptive clinical trial designs in medical research with insights from industry experts.
The Long Run with Luke Timmerman
In-depth conversations with biotech leaders navigating the challenges and opportunities of advancing science for human health.
Huberman Lab
Explores neuroscience and science-based tools for understanding and improving brain function, behavior, and health.
Inquiring Minds
Explores the intersection of science and society through critical thinking and in-depth analysis.
Bringing Chemistry to Life
Talks with leading chemists about their discoveries, careers, and the science shaping our world.
Space for Life
Honest conversations about creating emotional and spiritual space for a more fulfilling life.
The Life Scientific
A scientist discusses their research, inspirations, and career with physicist Jim Al-Khalili.
Space4U
Space Foundation
Cannabis Cultivation and Science Podcast
Experts discuss science-based organic cannabis cultivation techniques and advancements in growing technology.
The Pulse
Explores surprising stories in health and science, from operating rooms and labs to breakthrough innovations.
The Health Continuum
High-performing professionals learn science-based health strategies to sustain energy, focus, and resilience in demanding careers.
About The Space: Life Sciences Podcast
Marc Iskowitz, Beghou's editorial director, hosts behind-the-scenes conversations with biopharma executives. This series will feature leaders from across the biotech and pharma ecosystem, spanning commercial ops, field force, medical, marketing, analytics, market access, and beyond, sharing real-world lessons from the front lines of bringing therapies to patients.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from The Space: Life Sciences Podcast in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's The Space: Life Sciences Podcast daily summary?
It's a free AI-powered email that summarizes new episodes of The Space: Life Sciences Podcast as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the The Space: Life Sciences Podcast podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official The Space: Life Sciences Podcast product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Marc Iskowitz, Beghou.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
What topics does The Space: Life Sciences Podcast cover?
The Space: Life Sciences Podcast covers topics including Science, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting The Space: Life Sciences Podcast summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.